ID   LIS1_HUMAN              Reviewed;         410 AA.
AC   P43034; B2R7Q7; Q8WZ88; Q8WZ89;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 181.
DE   RecName: Full=Platelet-activating factor acetylhydrolase IB subunit alpha {ECO:0000255|HAMAP-Rule:MF_03141};
DE   AltName: Full=Lissencephaly-1 protein {ECO:0000255|HAMAP-Rule:MF_03141};
DE            Short=LIS-1 {ECO:0000255|HAMAP-Rule:MF_03141};
DE   AltName: Full=PAF acetylhydrolase 45 kDa subunit {ECO:0000255|HAMAP-Rule:MF_03141};
DE            Short=PAF-AH 45 kDa subunit {ECO:0000255|HAMAP-Rule:MF_03141};
DE   AltName: Full=PAF-AH alpha {ECO:0000255|HAMAP-Rule:MF_03141};
DE            Short=PAFAH alpha {ECO:0000255|HAMAP-Rule:MF_03141};
GN   Name=PAFAH1B1 {ECO:0000255|HAMAP-Rule:MF_03141};
GN   Synonyms=LIS1 {ECO:0000255|HAMAP-Rule:MF_03141}, MDCR, MDS, PAFAHA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Kidney;
RX   PubMed=8355785; DOI=10.1038/364717a0;
RA   Reiner O., Carrozzo R., Shen Y., Wehnert M., Faustinella F.,
RA   Dobyns W.B., Caskey C.T., Ledbetter D.H.;
RT   "Isolation of a Miller-Dieker lissencephaly gene containing G protein
RT   beta-subunit-like repeats.";
RL   Nature 364:717-721(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LIS1 ARG-149.
RX   PubMed=9063735; DOI=10.1093/hmg/6.2.157;
RA   Lo Nigro C., Chong S.S., Smith A.C.M., Dobyns W.B., Carrozzo R.,
RA   Ledbetter D.H.;
RT   "Point mutations and an intragenic deletion in LIS1, the lissencephaly
RT   causative gene in isolated lissencephaly sequence and Miller-Dieker
RT   syndrome.";
RL   Hum. Mol. Genet. 6:157-164(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Zhao M.J., Xia S.L., Li T.P.;
RT   "High expression of the lissencephaly gene in hepatocarcinoma
RT   patients.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Feng Z., Zhang B., Peng X., Yuan J., Qiang B.;
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH DCX.
RX   PubMed=11001923; DOI=10.1093/oxfordjournals.hmg.a018911;
RA   Caspi M., Atlas R., Kantor A., Sapir T., Reiner O.;
RT   "Interaction between LIS1 and doublecortin, two lissencephaly gene
RT   products.";
RL   Hum. Mol. Genet. 9:2205-2213(2000).
RN   [10]
RP   INTERACTION WITH NDE1, AND CHARACTERIZATION OF VARIANTS LIS1 ARG-149
RP   AND SBH PRO-169.
RX   PubMed=11163258; DOI=10.1016/S0896-6273(00)00145-8;
RA   Feng Y., Olson E.C., Stukenberg P.T., Flanagan L.A., Kirschner M.W.,
RA   Walsh C.A.;
RT   "LIS1 regulates CNS lamination by interacting with mNudE, a central
RT   component of the centrosome.";
RL   Neuron 28:665-679(2000).
RN   [11]
RP   SELF-ASSOCIATION, INTERACTION WITH RSN; DYNEIN AND DYNACTIN, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11889140; DOI=10.1083/jcb.200109046;
RA   Tai C.-Y., Dujardin D.L., Faulkner N.E., Vallee R.B.;
RT   "Role of dynein, dynactin, and CLIP-170 interactions in LIS1
RT   kinetochore function.";
RL   J. Cell Biol. 156:959-968(2002).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11940666; DOI=10.1128/MCB.22.9.3089-3102.2002;
RA   Coquelle F.M., Caspi M., Cordelieres F.P., Dompierre J.P.,
RA   Dujardin D.L., Koifman C., Martin P., Hoogenraad C.C., Akhmanova A.,
RA   Galjart N., De Mey J.R., Reiner O.;
RT   "LIS1, CLIP-170's key to the dynein/dynactin pathway.";
RL   Mol. Cell. Biol. 22:3089-3102(2002).
RN   [13]
RP   INTERACTION WITH NDEL1.
RX   PubMed=12556484; DOI=10.1128/MCB.23.4.1239-1250.2003;
RA   Yan X., Li F., Liang Y., Shen Y., Zhao X., Huang Q., Zhu X.;
RT   "Human Nudel and NudE as regulators of cytoplasmic dynein in poleward
RT   protein transport along the mitotic spindle.";
RL   Mol. Cell. Biol. 23:1239-1250(2003).
RN   [14]
RP   INTERACTION WITH NDEL1.
RX   PubMed=14970193; DOI=10.1083/jcb.200308058;
RA   Liang Y., Yu W., Li Y., Yang Z., Yan X., Huang Q., Zhu X.;
RT   "Nudel functions in membrane traffic mainly through association with
RT   Lis1 and cytoplasmic dynein.";
RL   J. Cell Biol. 164:557-566(2004).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, AND CHARACTERIZATION OF VARIANTS LIS1
RP   ARG-149; SBH PRO-169 AND LIS1 HIS-317.
RX   PubMed=15173193; DOI=10.1083/jcb.200309025;
RA   Tanaka T., Serneo F.F., Higgins C., Gambello M.J., Wynshaw-Boris A.,
RA   Gleeson J.G.;
RT   "Lis1 and doublecortin function with dynein to mediate coupling of the
RT   nucleus to the centrosome in neuronal migration.";
RL   J. Cell Biol. 165:709-721(2004).
RN   [16]
RP   INTERACTION WITH DISC1.
RX   PubMed=14962739; DOI=10.1016/j.mcn.2003.09.009;
RA   Brandon N.J., Handford E.J., Schurov I., Rain J.-C., Pelling M.,
RA   Duran-Jimeniz B., Camargo L.M., Oliver K.R., Beher D., Shearman M.S.,
RA   Whiting P.J.;
RT   "Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally
RT   regulated protein complex: implications for schizophrenia and other
RT   major neurological disorders.";
RL   Mol. Cell. Neurosci. 25:42-55(2004).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-53, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   FUNCTION.
RX   PubMed=22956769; DOI=10.1091/mbc.E12-03-0210;
RA   Splinter D., Razafsky D.S., Schlager M.A., Serra-Marques A.,
RA   Grigoriev I., Demmers J., Keijzer N., Jiang K., Poser I., Hyman A.A.,
RA   Hoogenraad C.C., King S.J., Akhmanova A.;
RT   "BICD2, dynactin, and LIS1 cooperate in regulating dynein recruitment
RT   to cellular structures.";
RL   Mol. Biol. Cell 23:4226-4241(2012).
RN   [20]
RP   INTERACTION WITH ASUN.
RX   PubMed=23097494; DOI=10.1091/mbc.E12-07-0558;
RA   Jodoin J.N., Shboul M., Sitaram P., Zein-Sabatto H., Reversade B.,
RA   Lee E., Lee L.A.;
RT   "Human Asunder promotes dynein recruitment and centrosomal tethering
RT   to the nucleus at mitotic entry.";
RL   Mol. Biol. Cell 23:4713-4724(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   VARIANT SBH PRO-169.
RX   PubMed=10441340; DOI=10.1093/hmg/8.9.1757;
RA   Pilz D.T., Kuc J., Matsumoto N., Bodurtha J., Bernadi B.,
RA   Tassinari C.A., Dobyns W.B., Ledbetter D.H.;
RT   "Subcortical band heterotopia in rare affected males can be caused by
RT   missense mutations in DCX (XLIS) or LIS1.";
RL   Hum. Mol. Genet. 8:1757-1760(1999).
RN   [23]
RP   VARIANTS LIS1 SER-31; SER-162 AND HIS-317.
RX   PubMed=11502906; DOI=10.1212/WNL.57.3.416;
RA   Leventer R.J., Cardoso C., Ledbetter D.H., Dobyns W.B.;
RT   "LIS1 missense mutations cause milder lissencephaly phenotypes
RT   including a child with normal IQ.";
RL   Neurology 57:416-422(2001).
RN   [24]
RP   VARIANT SBH PRO-241.
RX   PubMed=14581661; DOI=10.1212/WNL.61.8.1042;
RA   Sicca F., Kelemen A., Genton P., Das S., Mei D., Moro F., Dobyns W.B.,
RA   Guerrini R.;
RT   "Mosaic mutations of the LIS1 gene cause subcortical band
RT   heterotopia.";
RL   Neurology 61:1042-1046(2003).
RN   [25]
RP   VARIANT LIS1 PRO-277.
RX   PubMed=15007136; DOI=10.1212/01.WNL.0000113725.46254.FD;
RA   Torres F.R., Montenegro M.A., Marques-de-Faria A.P., Guerreiro M.M.,
RA   Cendes F., Lopes-Cendes I.;
RT   "Mutation screening in a cohort of patients with lissencephaly and
RT   subcortical band heterotopia.";
RL   Neurology 62:799-802(2004).
CC   -!- FUNCTION: Required for proper activation of Rho GTPases and actin
CC       polymerization at the leading edge of locomoting cerebellar
CC       neurons and postmigratory hippocampal neurons in response to
CC       calcium influx triggered via NMDA receptors. Non-catalytic subunit
CC       of an acetylhydrolase complex which inactivates platelet-
CC       activating factor (PAF) by removing the acetyl group at the SN-2
CC       position (By similarity). Positively regulates the activity of the
CC       minus-end directed microtubule motor protein dynein. May enhance
CC       dynein-mediated microtubule sliding by targeting dynein to the
CC       microtubule plus end. Required for several dynein- and
CC       microtubule-dependent processes such as the maintenance of Golgi
CC       integrity, the peripheral transport of microtubule fragments and
CC       the coupling of the nucleus and centrosome. Required during brain
CC       development for the proliferation of neuronal precursors and the
CC       migration of newly formed neurons from the
CC       ventricular/subventricular zone toward the cortical plate.
CC       Neuronal migration involves a process called nucleokinesis,
CC       whereby migrating cells extend an anterior process into which the
CC       nucleus subsequently translocates. During nucleokinesis dynein at
CC       the nuclear surface may translocate the nucleus towards the
CC       centrosome by exerting force on centrosomal microtubules. May also
CC       play a role in other forms of cell locomotion including the
CC       migration of fibroblasts during wound healing. Required for dynein
CC       recruitment to microtubule plus ends and BICD2-bound cargos
CC       (PubMed:22956769). {ECO:0000250|UniProtKB:P63005,
CC       ECO:0000269|PubMed:15173193, ECO:0000269|PubMed:22956769}.
CC   -!- SUBUNIT: Component of cytosolic PAF-AH IB, which is composed of
CC       PAFAH1B1 (alpha), PAFAH1B2 (beta) and PAFAH1B3 (gamma) subunits.
CC       Trimer formation is not essential for the catalytic activity of
CC       the enzyme which is contributed solely by the PAFAH1B2 (beta) and
CC       PAFAH1B3 (gamma) subunits. Interacts with IQGAP1, KATNB1 and NUDC.
CC       Interacts with DAB1 when DAB1 is phosphorylated in response to
CC       RELN/reelin signaling (By similarity). Can self-associate.
CC       Interacts with DCX, dynein, dynactin, NDE1, NDEL1 and RSN.
CC       Interacts with DISC1, and this interaction is enhanced by NDEL1.
CC       Interacts with ASUN. {ECO:0000250, ECO:0000269|PubMed:11001923,
CC       ECO:0000269|PubMed:11163258, ECO:0000269|PubMed:11889140,
CC       ECO:0000269|PubMed:12556484, ECO:0000269|PubMed:14962739,
CC       ECO:0000269|PubMed:14970193, ECO:0000269|PubMed:23097494}.
CC   -!- INTERACTION:
CC       Q9CZA6:Nde1 (xeno); NbExp=6; IntAct=EBI-720620, EBI-309934;
CC       Q9GZM8:NDEL1; NbExp=3; IntAct=EBI-720620, EBI-928842;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome.
CC       Cytoplasm, cytoskeleton, spindle {ECO:0000255|HAMAP-
CC       Rule:MF_03141}. Nucleus membrane {ECO:0000255|HAMAP-
CC       Rule:MF_03141}. Note=Redistributes to axons during neuronal
CC       development. Also localizes to the microtubules of the manchette
CC       in elongating spermatids and to the meiotic spindle in
CC       spermatocytes (By similarity). Localizes to the plus end of
CC       microtubules and to the centrosome. May localize to the nuclear
CC       membrane. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P43034-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P43034-2; Sequence=VSP_019376, VSP_019377, VSP_019378,
CC                                  VSP_019379;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Fairly ubiquitous expression in both the
CC       frontal and occipital areas of the brain.
CC   -!- DOMAIN: Dimerization mediated by the LisH domain may be required
CC       to activate dynein. {ECO:0000255|HAMAP-Rule:MF_03141}.
CC   -!- DISEASE: Lissencephaly 1 (LIS1) [MIM:607432]: A classical
CC       lissencephaly. It is characterized by agyria or pachygyria and
CC       disorganization of the clear neuronal lamination of normal six-
CC       layered cortex. The cortex is abnormally thick and poorly
CC       organized with 4 primitive layers. Associated with enlarged and
CC       dysmorphic ventricles and often hypoplasia of the corpus callosum.
CC       {ECO:0000269|PubMed:11163258, ECO:0000269|PubMed:11502906,
CC       ECO:0000269|PubMed:15007136, ECO:0000269|PubMed:15173193,
CC       ECO:0000269|PubMed:9063735}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Subcortical band heterotopia (SBH) [MIM:607432]: SBH is a
CC       mild brain malformation of the lissencephaly spectrum. It is
CC       characterized by bilateral and symmetric plates or bands of gray
CC       matter found in the central white matter between the cortex and
CC       cerebral ventricles, cerebral convolutions usually appearing
CC       normal. {ECO:0000269|PubMed:10441340,
CC       ECO:0000269|PubMed:14581661}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Miller-Dieker lissencephaly syndrome (MDLS) [MIM:247200]:
CC       A contiguous gene deletion syndrome of chromosome 17p13.3,
CC       characterized by classical lissencephaly and distinct facial
CC       features. Additional congenital malformations can be part of the
CC       condition. Note=The disease is caused by mutations affecting the
CC       gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the WD repeat LIS1/nudF family.
CC       {ECO:0000255|HAMAP-Rule:MF_03141}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA02882.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L13385; AAA02880.1; -; mRNA.
DR   EMBL; L13386; AAA02881.1; -; mRNA.
DR   EMBL; L13387; AAA02882.1; ALT_SEQ; mRNA.
DR   EMBL; U72342; AAC51111.1; -; Genomic_DNA.
DR   EMBL; U72334; AAC51111.1; JOINED; Genomic_DNA.
DR   EMBL; U72335; AAC51111.1; JOINED; Genomic_DNA.
DR   EMBL; U72336; AAC51111.1; JOINED; Genomic_DNA.
DR   EMBL; U72337; AAC51111.1; JOINED; Genomic_DNA.
DR   EMBL; U72338; AAC51111.1; JOINED; Genomic_DNA.
DR   EMBL; U72339; AAC51111.1; JOINED; Genomic_DNA.
DR   EMBL; U72340; AAC51111.1; JOINED; Genomic_DNA.
DR   EMBL; U72341; AAC51111.1; JOINED; Genomic_DNA.
DR   EMBL; AF208837; AAL34972.1; -; mRNA.
DR   EMBL; AF208838; AAL34973.1; -; mRNA.
DR   EMBL; AF400434; AAK92483.1; -; mRNA.
DR   EMBL; AK313078; BAG35904.1; -; mRNA.
DR   EMBL; BX538346; CAD98141.1; -; mRNA.
DR   EMBL; CH471108; EAW90536.1; -; Genomic_DNA.
DR   EMBL; BC064638; AAH64638.1; -; mRNA.
DR   CCDS; CCDS32528.1; -. [P43034-1]
DR   PIR; S36113; S36113.
DR   RefSeq; NP_000421.1; NM_000430.3. [P43034-1]
DR   RefSeq; XP_016880188.1; XM_017024699.1. [P43034-1]
DR   RefSeq; XP_016880189.1; XM_017024700.1. [P43034-1]
DR   RefSeq; XP_016880190.1; XM_017024701.1. [P43034-1]
DR   UniGene; Hs.77318; -.
DR   ProteinModelPortal; P43034; -.
DR   SMR; P43034; -.
DR   BioGrid; 111085; 67.
DR   DIP; DIP-35691N; -.
DR   IntAct; P43034; 30.
DR   MINT; MINT-5004233; -.
DR   STRING; 9606.ENSP00000380378; -.
DR   iPTMnet; P43034; -.
DR   PhosphoSitePlus; P43034; -.
DR   BioMuta; PAFAH1B1; -.
DR   DMDM; 1170794; -.
DR   EPD; P43034; -.
DR   MaxQB; P43034; -.
DR   PaxDb; P43034; -.
DR   PeptideAtlas; P43034; -.
DR   PRIDE; P43034; -.
DR   Ensembl; ENST00000397195; ENSP00000380378; ENSG00000007168. [P43034-1]
DR   GeneID; 5048; -.
DR   KEGG; hsa:5048; -.
DR   UCSC; uc002fuw.5; human. [P43034-1]
DR   CTD; 5048; -.
DR   DisGeNET; 5048; -.
DR   GeneCards; PAFAH1B1; -.
DR   GeneReviews; PAFAH1B1; -.
DR   HGNC; HGNC:8574; PAFAH1B1.
DR   HPA; CAB004489; -.
DR   HPA; HPA020036; -.
DR   MalaCards; PAFAH1B1; -.
DR   MIM; 247200; phenotype.
DR   MIM; 601545; gene.
DR   MIM; 607432; phenotype.
DR   neXtProt; NX_P43034; -.
DR   OpenTargets; ENSG00000007168; -.
DR   Orphanet; 217385; 17p13.3 microduplication syndrome.
DR   Orphanet; 95232; Lissencephaly due to LIS1 mutation.
DR   Orphanet; 531; Miller-Dieker syndrome.
DR   Orphanet; 99796; Subcortical band heterotopia.
DR   PharmGKB; PA32905; -.
DR   eggNOG; KOG0295; Eukaryota.
DR   eggNOG; ENOG410XP3K; LUCA.
DR   GeneTree; ENSGT00810000125363; -.
DR   HOGENOM; HOG000184015; -.
DR   HOVERGEN; HBG006271; -.
DR   InParanoid; P43034; -.
DR   KO; K16794; -.
DR   OMA; NWVRALV; -.
DR   OrthoDB; EOG091G07Q1; -.
DR   PhylomeDB; P43034; -.
DR   TreeFam; TF105741; -.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SignaLink; P43034; -.
DR   ChiTaRS; PAFAH1B1; human.
DR   GeneWiki; PAFAH1B1; -.
DR   GenomeRNAi; 5048; -.
DR   PRO; PR:P43034; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000007168; -.
DR   CleanEx; HS_PAFAH1B1; -.
DR   ExpressionAtlas; P43034; baseline and differential.
DR   Genevisible; P43034; HS.
DR   GO; GO:0000235; C:astral microtubule; IDA:UniProtKB.
DR   GO; GO:1904115; C:axon cytoplasm; IEA:GOC.
DR   GO; GO:0005938; C:cell cortex; IDA:UniProtKB.
DR   GO; GO:0031252; C:cell leading edge; IEA:Ensembl.
DR   GO; GO:0090724; C:central region of growth cone; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005871; C:kinesin complex; IEA:Ensembl.
DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.
DR   GO; GO:0005875; C:microtubule associated complex; IDA:UniProtKB.
DR   GO; GO:0031514; C:motile cilium; ISS:BHF-UCL.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:BHF-UCL.
DR   GO; GO:0032420; C:stereocilium; IEA:Ensembl.
DR   GO; GO:0034452; F:dynactin binding; ISS:BHF-UCL.
DR   GO; GO:0070840; F:dynein complex binding; IDA:UniProtKB.
DR   GO; GO:0045505; F:dynein intermediate chain binding; IEA:Ensembl.
DR   GO; GO:0008201; F:heparin binding; ISS:BHF-UCL.
DR   GO; GO:0008017; F:microtubule binding; ISS:BHF-UCL.
DR   GO; GO:0004623; F:phospholipase A2 activity; TAS:Reactome.
DR   GO; GO:0043274; F:phospholipase binding; ISS:BHF-UCL.
DR   GO; GO:0051219; F:phosphoprotein binding; ISS:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL.
DR   GO; GO:0001675; P:acrosome assembly; ISS:BHF-UCL.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISS:BHF-UCL.
DR   GO; GO:0008344; P:adult locomotory behavior; IMP:BHF-UCL.
DR   GO; GO:0001667; P:ameboidal-type cell migration; IEA:Ensembl.
DR   GO; GO:0060117; P:auditory receptor cell development; IEA:Ensembl.
DR   GO; GO:0048854; P:brain morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0021987; P:cerebral cortex development; IMP:BHF-UCL.
DR   GO; GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISS:BHF-UCL.
DR   GO; GO:0097711; P:ciliary basal body docking; TAS:Reactome.
DR   GO; GO:0090102; P:cochlea development; IEA:Ensembl.
DR   GO; GO:0021540; P:corpus callosum morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0043622; P:cortical microtubule organization; IEA:Ensembl.
DR   GO; GO:0051660; P:establishment of centrosome localization; IEA:Ensembl.
DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB.
DR   GO; GO:0042249; P:establishment of planar polarity of embryonic epithelium; IEA:Ensembl.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0007281; P:germ cell development; IBA:GO_Central.
DR   GO; GO:0021766; P:hippocampus development; ISS:BHF-UCL.
DR   GO; GO:0021819; P:layer formation in cerebral cortex; ISS:BHF-UCL.
DR   GO; GO:0007611; P:learning or memory; ISS:BHF-UCL.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0051661; P:maintenance of centrosome location; IEA:Ensembl.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; ISS:BHF-UCL.
DR   GO; GO:0090176; P:microtubule cytoskeleton organization involved in establishment of planar polarity; IEA:Ensembl.
DR   GO; GO:0031023; P:microtubule organizing center organization; IMP:UniProtKB.
DR   GO; GO:0007017; P:microtubule-based process; IDA:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0046329; P:negative regulation of JNK cascade; IEA:Ensembl.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0007405; P:neuroblast proliferation; ISS:BHF-UCL.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IMP:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; IMP:UniProtKB.
DR   GO; GO:0051081; P:nuclear envelope disassembly; IEA:Ensembl.
DR   GO; GO:0007097; P:nuclear migration; IBA:GO_Central.
DR   GO; GO:0036035; P:osteoclast development; IEA:Ensembl.
DR   GO; GO:0046469; P:platelet activating factor metabolic process; ISS:BHF-UCL.
DR   GO; GO:0045773; P:positive regulation of axon extension; IEA:Ensembl.
DR   GO; GO:0001961; P:positive regulation of cytokine-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IEA:Ensembl.
DR   GO; GO:0040019; P:positive regulation of embryonic development; IEA:Ensembl.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0009306; P:protein secretion; IEA:Ensembl.
DR   GO; GO:0043087; P:regulation of GTPase activity; IEA:Ensembl.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:2000574; P:regulation of microtubule motor activity; IBA:GO_Central.
DR   GO; GO:0008090; P:retrograde axonal transport; ISS:BHF-UCL.
DR   GO; GO:0007062; P:sister chromatid cohesion; TAS:Reactome.
DR   GO; GO:0017145; P:stem cell division; IEA:Ensembl.
DR   GO; GO:0019226; P:transmission of nerve impulse; ISS:BHF-UCL.
DR   GO; GO:0047496; P:vesicle transport along microtubule; ISS:BHF-UCL.
DR   HAMAP; MF_03141; lis1; 1.
DR   InterPro; IPR017252; Dynein_regulator_LIS1.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR006594; LisH.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   Pfam; PF08513; LisH; 1.
DR   Pfam; PF00400; WD40; 7.
DR   PIRSF; PIRSF037647; Dynein_regulator_Lis1; 1.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00667; LisH; 1.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50896; LISH; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 4.
DR   PROSITE; PS50082; WD_REPEATS_2; 7.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell cycle; Cell division;
KW   Coiled coil; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Developmental protein; Differentiation; Disease mutation;
KW   Lipid degradation; Lipid metabolism; Lissencephaly; Membrane;
KW   Microtubule; Mitosis; Neurogenesis; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transport; WD repeat.
FT   CHAIN         1    410       Platelet-activating factor
FT                                acetylhydrolase IB subunit alpha.
FT                                /FTId=PRO_0000051061.
FT   DOMAIN        7     39       LisH. {ECO:0000255|HAMAP-Rule:MF_03141}.
FT   REPEAT      106    147       WD 1.
FT   REPEAT      148    187       WD 2.
FT   REPEAT      190    229       WD 3.
FT   REPEAT      232    271       WD 4.
FT   REPEAT      274    333       WD 5.
FT   REPEAT      336    377       WD 6.
FT   REPEAT      378    410       WD 7.
FT   REGION        1    102       Interaction with NDEL1.
FT                                {ECO:0000255|HAMAP-Rule:MF_03141}.
FT   REGION        1     66       Interaction with NDE1.
FT                                {ECO:0000255|HAMAP-Rule:MF_03141}.
FT   REGION        1     38       Required for self-association and
FT                                interaction with PAFAH1B2 and PAFAH1B3.
FT                                {ECO:0000255|HAMAP-Rule:MF_03141}.
FT   REGION       83    410       Interaction with dynein and dynactin.
FT   REGION      367    409       Interaction with DCX.
FT                                {ECO:0000269|PubMed:11001923}.
FT   REGION      388    410       Interaction with NDEL1.
FT                                {ECO:0000255|HAMAP-Rule:MF_03141}.
FT   COILED       56     82       {ECO:0000255|HAMAP-Rule:MF_03141}.
FT   MOD_RES      53     53       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     109    109       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      12     64       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_019376.
FT   VAR_SEQ     134    170       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_019377.
FT   VAR_SEQ     237    237       V -> I (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_019378.
FT   VAR_SEQ     238    410       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_019379.
FT   VARIANT      31     31       F -> S (in LIS1; dbSNP:rs121434486).
FT                                {ECO:0000269|PubMed:11502906}.
FT                                /FTId=VAR_015398.
FT   VARIANT     149    149       H -> R (in LIS1; abrogates interaction
FT                                with NDE1 and reduces neuronal migration
FT                                in vitro; dbSNP:rs121434482).
FT                                {ECO:0000269|PubMed:11163258,
FT                                ECO:0000269|PubMed:15173193,
FT                                ECO:0000269|PubMed:9063735}.
FT                                /FTId=VAR_007724.
FT   VARIANT     162    162       G -> S (in LIS1; dbSNP:rs28936410).
FT                                {ECO:0000269|PubMed:11502906}.
FT                                /FTId=VAR_015399.
FT   VARIANT     169    169       S -> P (in SBH; abrogates interaction
FT                                with NDE1 and reduces neuronal migration
FT                                in vitro; dbSNP:rs121434484).
FT                                {ECO:0000269|PubMed:10441340,
FT                                ECO:0000269|PubMed:11163258,
FT                                ECO:0000269|PubMed:15173193}.
FT                                /FTId=VAR_010203.
FT   VARIANT     241    241       R -> P (in SBH; somatic mosaicism in 18%
FT                                of lymphocytes and 21% of hair root
FT                                cells; dbSNP:rs28936411).
FT                                {ECO:0000269|PubMed:14581661}.
FT                                /FTId=VAR_037300.
FT   VARIANT     277    277       H -> P (in LIS1; dbSNP:rs121434490).
FT                                {ECO:0000269|PubMed:15007136}.
FT                                /FTId=VAR_037301.
FT   VARIANT     317    317       D -> H (in LIS1; reduces neuronal
FT                                migration in vitro; dbSNP:rs28936689).
FT                                {ECO:0000269|PubMed:11502906,
FT                                ECO:0000269|PubMed:15173193}.
FT                                /FTId=VAR_015400.
FT   CONFLICT     21     21       S -> P (in Ref. 3; AAL34972/AAL34973).
FT                                {ECO:0000305}.
FT   CONFLICT     93     93       E -> G (in Ref. 3; AAL34973).
FT                                {ECO:0000305}.
FT   CONFLICT    177    177       W -> R (in Ref. 3; AAL34973).
FT                                {ECO:0000305}.
SQ   SEQUENCE   410 AA;  46638 MW;  3AB68D2641BA31C9 CRC64;
     MVLSQRQRDE LNRAIADYLR SNGYEEAYSV FKKEAELDVN EELDKKYAGL LEKKWTSVIR
     LQKKVMELES KLNEAKEEFT SGGPLGQKRD PKEWIPRPPE KYALSGHRSP VTRVIFHPVF
     SVMVSASEDA TIKVWDYETG DFERTLKGHT DSVQDISFDH SGKLLASCSA DMTIKLWDFQ
     GFECIRTMHG HDHNVSSVAI MPNGDHIVSA SRDKTIKMWE VQTGYCVKTF TGHREWVRMV
     RPNQDGTLIA SCSNDQTVRV WVVATKECKA ELREHEHVVE CISWAPESSY SSISEATGSE
     TKKSGKPGPF LLSGSRDKTI KMWDVSTGMC LMTLVGHDNW VRGVLFHSGG KFILSCADDK
     TLRVWDYKNK RCMKTLNAHE HFVTSLDFHK TAPYVVTGSV DQTVKVWECR
//
